Premium
Efficacy and tolerance of immune checkpoint inhibitors for non‐small cell lung cancer patients with interstitial lung disease – Reply
Author(s) -
Kobayashi Haruki
Publication year - 2020
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13785
Subject(s) - medicine , lung cancer , interstitial lung disease , disease , lung , lung disease , oncology
See Letter